The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04586491

Recruitment Status : Completed

First Posted : October 14, 2020

Last Update Posted : October 19, 2020

Sponsor:

Information provided by (Responsible Party):

Gülçin Özalp Gerçeker, Dokuz Eylul University

Study Description

Brief Summary:

This study conducted to determine the effects of two oral care protocols containing sodium bicarbonate or saline solution in the prevention of oral mucositis (OM), mucositis degree, and recovery time in children with cancer.

Condition or disease	Intervention/treatment	Phase
Mucositis Pediatric Cancer Oral Cavity	Combination Product: Oral care protocol	Not Applicable

Detailed Description:

The study conducted as a randomized controlled trial with a parallel design with two groups; Study group/ Oral care protocol with saline solution Control group/ Oral care protocol with sodium bicarbonate solution

Study Hypothesis; There is a difference in oral mucositis (OM) between groups. There is a difference in the degree of OM between groups. There is a difference in the OM recovery time between groups. There is a difference in demographic variables in patients with and without mucositis.

The study sample was comprised of 43 children with cancer aged 1-17 years, received chemotherapy for ≥3 days at inpatient clinics, and whose families agreed to their participation in the study. Patients excluded who have oral ulceration or mucositis, taking any antiviral or antifungal therapy for OM before enrollment in the study. This trial was a triple blinded which the patients/parents, nurses, and the investigators have no idea about the groups.

In the study, patients were allocated by the blocked randomization. After naturally separating the gender variable into 2 layers, the age was divided into 5 layers as "<1 year, 1-3 years,>3-6 years, 6-12 years,>12 years", and the diagnosis variable was divided into 3 layers as "ALL, AML and oncological tumors."

Socio-Demographic Data Collection Form, International Child Mucositis Rating Scale (CHIMES), and Mucositis Follow-up Form used.

The child who do not have mucositis and who will be hospitalized for more than 3 days for chemotherapy will be distributed to the groups by stratified randomization method, the information of the patients will be obtained with the sociodemographic data collection form, oral care training will be given to the patient and the family, oral care protocol will be applied and it will be evaluated daily with the CHIMES and Mucositis Follow-up Form, and the severity of mucositis according to the World Health Organization Mucositis Assessment Index, the mean score of the CHIMES, recovery time will be monitored through the Mucositis Follow-up Form.

Study Design

Layout table for study information

Study Type :	Interventional (Clinical Trial)
Actual Enrollment :	40 participants
Allocation:	Randomized
Intervention Model:	Parallel Assignment
Intervention Model Description:	Prospective, randomised, parallel trial design
Masking:	Single (Participant)
Primary Purpose:	Prevention
Official Title:	The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients
Actual Study Start Date :	October 7, 2019
Actual Primary Completion Date :	February 10, 2020
Actual Study Completion Date :	February 10, 2020

Arms and Interventions

Arm	Intervention/treatment
Experimental: Study group/ Oral care protocol with saline solution All patients took oral care protocol in the unit with saline solution	Combination Product: Oral care protocol Oral care protocol Other Names: Daily evaluation of the inside of the mouth with the ChIMES Gargle with solution wiping the inside of the mouth with solution and sterile sponge Brushing teeth with a soft toothbrush if platelet value was > 50000mm3. Training for the child and family in oral care.
Experimental: Control group/ Oral care protocol with sodium bicarbonate solution All patients took oral care protocol in the unit with sodium bicarbonate solution	Combination Product: Oral care protocol Oral care protocol Other Names: Daily evaluation of the inside of the mouth with the ChIMES Gargle with solution wiping the inside of the mouth with solution and sterile sponge Brushing teeth with a soft toothbrush if platelet value was > 50000mm3. Training for the child and family in oral care.

Outcome Measures

Primary Outcome Measures :

development of oral mucositis [ Time Frame: until discharge from the hospital an average 1 week ]
WHO Oral Mucositis Grading Scale: The WHO scale is dependent on both objective and subjective variables, and measures anatomical, symptomatic as well as functional components of oral mucositis.

WHO Oral Mucositis Grading Scale

Secondary Outcome Measures :

severity of oral mucositis [ Time Frame: until discharge from the hospital an average 1 week ]
WHO Oral Mucositis Grading Scale: The WHO scale is dependent on both objective and subjective variables, and measures anatomical, symptomatic as well as functional components of oral mucositis.

the Children's International Mucositis Evaluation Scale (ChIMES):It consists of seven elements: (1) Amount of mouth or throat pain(ChIMES1), (2) Effect of mouth or throat pain on swallowing(ChIMES2), (3) Effect of mouth or throat pain oneating (ChIMES3), (4) Effect of mouth or throat pain ondrinking (ChIMES4), (5) Receipt of pain medication (ChIMES5),(6) Receipt of pain medication for mouth or throat pain(ChIMES6), and (7) Presence of ulcers (ChIMES7).
recovery time of oral mucositis [ Time Frame: until discharge from the hospital an average 1 week ]
Mucositis Follow-up Form used for the recovery time

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information

Ages Eligible for Study:	1 Year to 17 Years (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

have cancer, aged 1-17 years, received chemotherapy for ≥3 days at inpatient clinics and whose families agreed to their participation in the study.

Exclusion Criteria:

who have oral ulceration or mucositis, in terminal period, taking any antiviral or antifungal therapy for OM before enrollment in the study.

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04586491

Locations

Layout table for location information

Turkey
Gülçin Özalp Gerçeker
İzmir, Turkey, 35100

Sponsors and Collaborators

Dokuz Eylul University

More Information

Layout table for additonal information

Responsible Party:	Gülçin Özalp Gerçeker, Dokuz Eylul University
ClinicalTrials.gov Identifier:	NCT04586491
Other Study ID Numbers:	Gülçin Özalp Gerçeker
First Posted:	October 14, 2020 Key Record Dates
Last Update Posted:	October 19, 2020
Last Verified:	October 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD:	No

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:	No
Studies a U.S. FDA-regulated Device Product:	No

Additional relevant MeSH terms:

Layout table for MeSH terms

Mucositis Stomatitis Gastroenteritis Gastrointestinal Diseases	Digestive System Diseases Mouth Diseases Stomatognathic Diseases Pharmaceutical Solutions

To Top